Fig. 3: Mean VA change through year 1 by injection frequency during year 1 in eyes with MO secondary to BRVO.

Analysis included eyes with available VA measurements through Year 1. BRVO branch retinal vein occlusion, BSL baseline, ETDRS Early Treatment Diabetic Retinopathy Study, MO macular oedema, Q quarter, VA visual acuity.